Comment
doi: 10.1016/S0140-6736(08)61813-9.
Epub 2008 Dec 4.
Let there be sleep--on time
Affiliations
- PMID: 19054553
- DOI: 10.1016/S0140-6736(08)61813-9
Item in Clipboard
Comment
Let there be sleep--on time
Lancet.
.
No abstract available
Comment on
-
Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.Lancet. 2009 Feb 7;373(9662):482-91. doi: 10.1016/S0140-6736(08)61812-7. Epub 2008 Dec 4. Lancet. 2009. PMID: 19054552 Clinical Trial.
Similar articles
-
[Melatonin receptor agonist].Nihon Rinsho. 2015 Jun;73(6):1017-22. Nihon Rinsho. 2015. PMID: 26065135 Review. Japanese.
-
Ramelteon: a melatonin receptor agonist for the treatment of insomnia.J Postgrad Med. 2008 Jan-Mar;54(1):45-8. doi: 10.4103/0022-3859.39193. J Postgrad Med. 2008. PMID: 18296808
-
[Preclinical pharmacological profiles and clinical outcome of the novel melatonin-receptor agonist ramelteon (Rozerem 8 mg).].Nihon Yakurigaku Zasshi. 2010 Jul;136(1):51-60. doi: 10.1254/fpj.136.51. Nihon Yakurigaku Zasshi. 2010. PMID: 20628215 Review. Japanese. No abstract available.
-
Drug Insight: the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon.Nat Clin Pract Neurol. 2007 Apr;3(4):221-8. doi: 10.1038/ncpneuro0467. Nat Clin Pract Neurol. 2007. PMID: 17410109 Review.
-
Ramelteon: new drug. Insomnia: no role for risky placebos.Prescrire Int. 2008 Oct;17(97):183-6. Prescrire Int. 2008. PMID: 19534018
Cited by
-
Pharmacotherapy of insomnia with ramelteon: safety, efficacy and clinical applications.J Cent Nerv Syst Dis. 2011 Apr 12;3:51-65. doi: 10.4137/JCNSD.S1611. Print 2011. J Cent Nerv Syst Dis. 2011. PMID: 23861638 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
